08:06 AM EST, 01/27/2025 (MT Newswires) -- GSK (GSK) said Monday that the European Medicines Agency has agreed to review its prefilled syringe version of Shingrix, a vaccine for the prevention of shingles.

The company said the prefilled syringes do away with the need to mix separate vials before jabs.

The regulatory review follows the Jan. 8 US Food and Drug Administration acceptance of the prefilled syringes, the company said.

GSK said it is also considering submitting the product for review in other markets.